Drs. Shebani Sethi and Judy Ford call for more clinical trials to address the potential beneficial effects of the ketogenic diet in people with serious mental illness.
New Results: First RCT for Schizophrenia & Bipolar Disorder. Learn more.
Drs. Shebani Sethi and Judy Ford call for more clinical trials to address the potential beneficial effects of the ketogenic diet in people with serious mental illness.
Lamotrigine treats both epilepsy and bipolar disorder via shared neurobiology. This review explores whether therapeutic ketosis may synergistically enhance mood stabilization and metabolic health.
Read more
This retrospective study found a 12-week remote ketogenic metabolic therapy program feasible and associated with reduced depression and anxiety symptoms in adults with varying mental health conditions.
Read more
This perspective review examines bipolar disorder through a metabolic lens. It highlights how nutrition, seasonal light, and metabolic shifts may contribute to symptom instability.
Read more